A real-world comparison of nivolumab plus cabozantinib and pembrolizumab plus lenvatinib focusing on safety outcomes in metastatic renal cell carcinoma: results from the JK-FOOT consortium
一项针对转移性肾细胞癌患者的真实世界研究比较了纳武利尤单抗联合卡博替尼和帕博利珠单抗联合乐伐替尼的安全性结果:来自 JK-FOOT 联盟的研究结果
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04288-6
Yanagisawa, Takafumi; Mori, Keiichiro; Kawada, Tatsushi; Katayama, Satoshi; Tsujino, Takuya; Maenosono, Ryoichi; Toyoda, Shingo; Nukaya, Takuhisa; Morinaka, Hirofumi; Tamura, Keita; Fukuokaya, Wataru; Urabe, Fumihiko; Murakami, Masaya; Bekku, Kensuke; Takahara, Kiyoshi; Fujita, Kazutoshi; Azuma, Haruhito; Araki, Motoo; Inamoto, Teruo; Komura, Kazumasa; Kimura, Takahiro